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ABSTRACT
Objective: Drug-related problems (DRPs) are frequent in hospitalization where multiple changes in patient’s medication regimen, and lack of 
continuity of care may be accompanied. The aim of present research was to identify DRPs, drug classes involved in DRPs as well as associated factors 
with the occurrence of DRPs and to assess the pharmacist interventions in a tertiary care teaching hospital.
Methods: A prospective observational study was carried out in a tertiary care teaching hospital, over a period of 6-month from November 2015 to 
April 2016. All the in patients admitted to all departments of hospital, who satisfied the selection criteria, were included in this study. Necessary 
demographic and clinical data were collected from the case records. The Pharmaceutical Care Network Europe Classification Version 5.01 was used to 
classify DRPs. The treatment data were analyzed to determine the rate, pattern, clinical significance, and outcomes of DRPs.
Results: A total of 300 patient case sheets were reviewed during the study, out of which 143 DRPs were identified from 93 patients. Male (%) 
predominance was noted over females (%). The most common DRP was drug interactions 47.55% (68) followed by drug use problems 19.58% (28), 
drug choice problems 14.68% (21), others 11.88% (17), dosing problems 4.89% (7), and adverse reaction 1.39% (2) were identified.
Conclusion: DRPs are common among the wards of hospital. Clinical pharmacist’s role in identification, resolution, and prevention of DRPs helps in 
achieving better therapeutic outcomes and improved patient healthcare.
Keywords: Drug-related problems, Adverse drug reactions, Drug interactions, Drug choice problems, Dosing problem, Drug use problems, Pediatric, 
Medicine, Pharmaceutical Care Network Europe Classification.
INTRODUCTION
Drug-related problems (DRPs) are events or circumstances involving 
drug therapy that actually or potentially interfere with desired health 
outcomes [1]. DRP can be manifested in several ways. DRPs may arise 
at all stages of the medication process from prescription to follow-up 
of treatment. Most of the problem usually occurs on administration, 
dispensing and during the patient’s use of a medicinal product, but 
the lack of proper follow-up and reassessment of medical treatment 
by the physician is also a major problem [2]. DRPs occur more 
frequently in hospitalized patients where multiple changes are being 
made in patient’s medication regimens, and lack of continuity of care 
may be accompanied [3]. The most common problems associated 
with drug use are many and includes inappropriate medication 
prescribing, discrepancies between prescribed and actual regimens, 
poor adherence, drug interactions (DI), inappropriate use, patients 
monitoring, inadequate surveillance for adverse effects, etc. DRPs lead 
to substantial morbidity, mortality as well as increased health-care 
expenditure which in turn affect the patient’s quality of life [4]. A mean 
of categorizing DRPs is considered necessary to better focus the role of 
the pharmacist on the patient need and patient outcome [5]. Keeping 
in account, their characteristics and distinctions, all medicine-related 
problems can be classified in many ways. Furthermore, classification 
of DRPs can serve as a cynosure for establishing a systematic process 
for pharmacists to put in appreciably to positive patient outcomes [6]. 
Among classifications which are continuously tested is Pharmaceutical 
Care Network Europe Classification (PCNE) classification. Its basic 
classification has 4 primary domains for problems, 8 primary domains 
for causes, 5 primary domains for interventions, and 4 primary domains 
for outcome of intervention [7]. The role of pharmacists is expanding 
in primary care. Pharmaceutical care identifies and resolves actual or 
potential DRPs [8]. The traditional relationship between the doctor 
as prescriber, and pharmacist as dispenser, is no longer appropriate 
to ensure safety, effectiveness, and adherence to therapy. Pharmacists 
need to pay more attention to patient-centered, outcomes-focused care 
to optimize the safe and effective use of medicines [9]. Several studies 
conducted in developed countries shows the high evidence of drug-
related errors among hospitalized patients. The studies related to the 
prevalence of DRPs is lacking in India, however, some of the studies 
conducted Indian hospital shown much evidence of DRPs and also 
reflects positive impact of pharmacist intervention on reducing drug-
related errors and overall patients care [10]. Hence, the purpose of this 
study was to assess and evaluate the DRPs in a tertiary care teaching 
hospital.
METHODS
The prospective, observational, and interventional study was conducted 
for 6-month from November 2015 to April 2016 at Navodaya Medical 
College Hospital and Research Centre (NMCH & RC), Raichur, Karnataka 
which is 1000 bedded multi-specialty tertiary care teaching hospital. 
Case sheets of patients who were admitted to all departments of the 
hospital and any disease and age group was taken for the study. The 
study was approved by Institutional Ethical Committee of the hospital 
and verbal consent from patients was taken. Exclusion criteria involved 
all the casebooks of outpatients. The study materials included the 
patient data entry form (includes patient and administration details), 
DRPs documenting form and PCNE guidelines.
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Pharmacist routinely monitored the patient’s drug therapy during 
their hospital stay. The prescriptions were chosen randomly, and/or 
the details were followed till discharge of the patients. The data for 
the present study was collected by chart review method. During the 
study inpatient case, records/sheets were reviewed, which included 
patients case history, diagnosis, physician medication order sheets, 
nurse medication administration records, progress chart, laboratory 
investigations, and report of other diagnostic tests. The necessary 
information was documented in the patient profile form. Demographic 
data were calculated and expressed as percentages. All the case sheets 
were checked for DRPs by the Micromedex (mobile version), drugs.
Com database and various textbooks along with the interview from 
patients and other health-care professionals and evaluated as per PCNE 
classification. The data from case sheets were checked for side effects 
both allergic and non-allergic, toxic effect, inappropriate drug or drug 
form, duplication of active ingredient, contraindication, treatment 
without indication, untreated indication, low dose and frequency, high 
dose and frequency, improper drug use, interaction, patient satisfaction, 
and other unclear complaints with therapy failure. Whenever DRP was 
identified, during the review, data from patient data entry form were 
transferred to DRPs documenting form.
The study data were analyzed using suitable statistical procedures in 
Microsoft Excel and word 2007. For descriptive statistics, results were 
expressed in terms of percentages and presented using tables and 
diagrams according to the types of tool used.
RESULTS
In the present study, an attempt was made to assess the DRP’s in 
our NMCH & RC - A tertiary care teaching hospital. The DRP’s were 
assessed by identifying the problems, categorizing them which helps in 
designing the proper intervention based on the problems. The patient’s 
data were collected as per standard data entry form and initially 
demographic analysis of the patients was done. The study showed 
that more male patients (61.33%) were admitted to the hospital than 
female. It was observed that majority of the patients were unmarried 
(52.67%). In this study, more number of patients enrolled was in the 
age group, 0-14 years (31%). The demographic details are presented 
in Table 1. The hospitalized inpatients were evaluated for various 
clinical characteristics. It was observed that ward wise distribution of 
the population showed more number of patients (25.33%) admitted 
in general medicine ward. Out of 300 patients, majority patients were 
hospitalized for more than 5 days (46.67%), which was followed by the 
patients hospitalized for 3-5 days (30.67%) and patients hospitalized 
for <3 days (22.67%). In this study, more number of the patients were 
free from any DRPs issues (69%) (Table 2). This result may be due to 
the proper precaution by health-care professionals and patient during 
drug prescribing and drug use. In a total of 300 cases followed, 93 cases 
were identified with 143 DRPs. Among that 53.76% (50) cases had 
only one problem, 38.70% (36) cases had two problems and remaining 
7.52% (7) had three problems during their hospital stay. The overall 
incidence of DRPs was found to be 47.66%. The clinical details of study 
subjects are given in Table 2.
In the 143 DRPs identified, 1.39% (2) are adverse reactions, 14.68% 
(21) are drug choice problems, 4.89% (7) are dosing problem, 19.58% 
(28) are drug use problems, 47.55% (68) are drug interaction, and 
11.88% (17) are other problems such as patient dissatisfaction, 
insufficient awareness of health and diseases, and therapy failure 
(Table 3). Age-wise distribution of DRPs showed a higher incidence of 
DRPs in the age group 25-39 years (Fig. 1).
When we come to domain classification of DRP’s off the total 143 DRPs 
1.39% (2) DRPs were side effect suffered (allergic) which comes under 
problem-adverse reaction, 6.30% (9) DRPs were no drug prescribed 
for clear indication which comes under-drug choice problem, 2.09% 
(3) DRPs were treatment duration too short which comes under dosing 
problem, 16.08% (23) DRPs were drug not taken at all which comes 
under problem drug use, 2.09% (3) DRPs were treatment duration too 
Table 1: Demographic details of study subjects (n=300)
Demographic variables Inpatients













Table 2: Clinical characteristics of study subjects (n=300)
Variables Inpatients (n=300)*




















Total DRP’s=143 in 93 cases
*(n=300) represents total no of subjects (n=93), †Represents total no 
of DRP cases. ICU: Intensive care unit, OBG: Obstetrics and Gynecology, 
DRP’s: Drug-related problems
Table 3: Types of DRP’s identified (n=143)
Types of DRP’s Number of DRP’s observed (%)
Adverse reaction 2 (1.39)
Drug choice problems 21 (14.68)
Dosing problems 7 (4.89)




short which comes under dosing problem, 46.10% (66) DRPs were 
potential interactions which come under problem drug interaction and 
7.76% (11) DRPs were insufficient awareness of health and disease 
which comes under other problems. The domain classification of DRPs 
according to PCNE classification (Version 5.01) is given in Table 4. 
Class-wise categorization of drugs involved in DRP’s indicated that the 
most problem causing drug was antibiotics (33.5%) followed by drugs 
acting on gastrointestinal tract (GIT) - 29.3% as shown in Fig. 2.
DISCUSSION
Drugs are the absolute therapeutic tools used in diseased condition in 
hospitalized patients. Drugs are intended to cure, prevent or diagnose 
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a disease, but improper use of drugs may cause patient morbidity 
and even mortality. Over the years, advancement in drug therapy has 
enhanced patient care but also led to increase in the incidence of DRPs. 
DRPs arise at all stages of the medication process from prescription 
to follow-up of the treatment. Clinical pharmacists are the heart of 
the clinical pharmacy services whose aim is safe and effective use of 
medicines. Clinical pharmacists play an important role in identifying 
DRP’s, resolving actual DRP’s, and preventing potential DRP’s thereby 
improving the well-being of the patients.
In the present study, an attempt was made to assess the DRP’s 
in NMCH & RC a tertiary care teaching hospital. The DRP’s were 
assessed by identifying the problems, categorizing them which helps 
in designing the proper intervention based on the problems. The 
patient’s data were collected as per standard data entry form and 
initially demographic analysis of the patients was done. The study 
showed that more male patients were admitted to the hospital than 
female. A similar prospective observational and interventional study 
conducted by Ganachari et al., [11] from Belgaum, India also reported 
male (58.06%) predominance over females (41.93%). Furthermore, a 
similar observation was reported from Rijo et al., from Kochi, Kerala 
where 59.4% of male patients were admitted compared to 40.6% 
females [12]. It was observed that majority of the patients were 
unmarried (Table 1). More number of patients enrolled for the study 
was in age group, 0-14 years. This may be due to less admission of 
elderly patients because of the unpleasant ambulatory condition. The 
ward-wise distribution of the population showed more number of 
patients admitted in general medicine ward (Table 2). The geographical 
location, challenging climatic condition, and pollution of this place 
leading to seasonal diseases, infections, and allergies might be the cause 
for the higher admission of patients in medicine ward than others.
Of 300 patients, majority patients were hospitalized for more than 
5 days, which is followed by the patients hospitalized for 3-5 days and 
patients hospitalized for <3 days (Table 2). It was observed that most 
of the patients visit the hospital only at the severe form of the simple 
disease. Thus the condition getting worst led them for prolonged 
hospital stay that will impact on their economic status. These can be 
avoided with proper awareness at the village and community level, 
more interactive health camps, posts and health education. It was 
observed that more number of patients were free from any DRPs 
issues (Table 2). In addition, a similar result was found in the study 
conducted by Ahmad and Khan [13]. This result may be due to the 
proper precaution by health-care professionals and patient during drug 
prescribing and drug use.
In total, 143 DRPs were identified in 93 patients. Although the patients 
with DRPs are less, the total number of DRPs is more which is due to 
the presence of more than one DRP in one case of the patient. Of the 
93 patients, the majority of them had 1 DRPs followed by patients with 
2 DRPs and patients with 3 DRPs (Table 2). The contributing factors 
are perhaps polypharmacy, prescribing multiple drugs for the same 
patient leading to more than one DRP. This report is similar to one 
reported by Arvind and Shobha [14]. The gender wise distribution of 
DRPs study showed higher incidence of DRPs in males 58.06% over 
females 41.94%. A similar result was observed with study conducted 
by Dinesh et al., [15]. This may be attributed to the fact that more 
number of patient cases selected for study was males than females. 
Age-wise distribution of DRPs showed a higher incidence of DRPs in 
Fig. 1: Age-wise distribution of drug-related problems (DRPs) 
(n=93). n=93 is number of subjects detected with DRP’s
Fig. 2: Class-wise categorization of drugs involved in drug-related 
problems (n=143)
Table 4: Domain classification of DRPs (n=143)
Code Problems Number of problems (%)
P1 Adverse reaction
Side effects suffered (allergic) 2 (1.39)
P2 Drug choice problems
Inappropriate drug 2 (1.39)
Inappropriate duplication of therapeutic group or active ingredient 5 (3.50)
No clear indication for drug use 5 (3.50)
No drug prescribed but clear indication 9 (6.29)
P3 Dosing problems
Drug dose too low or dosage regimen not frequent enough 2 (1.39)
Drug dose too high or dosage regimen too frequent 2 (1.39)
Duration of treatment too short 3 (2.09)
P4 Drug use problems
Drug not taken/administered at all 23 (16.08)
Wrong drug taken/administered 5 (3.50)
P5 Drug interaction
Potential interaction 66 (46.1)
Manifest interaction 2 (1.40)
P6 Others
Patient dissatisfied with therapy despite taking drug (s) correctly 4 (2.83)
Insufficient awareness of health and diseases 11 (7.66)
Therapy failure (reason unknown) 2 (1.39)
DRP’s: Drug-related problems
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the age group 25-39 (34.40%). This may be due to more no of drugs 
prescribed to this age group and the fact that second large number 
of patient cases selected for the study was also from this age group. 
Although the number of patients enrolled in the study was more from 
the age group 0-14 years, the problems associated with this age group 
was less. This may be because the proper care in drug use was provided 
in the pediatrics than the other age group. The administration of drugs 
in pediatric patients was guarded by parents, which also results in 
reduction in DRPs. When it comes to domain classification of DRP’s, 
the most problem causing drug was antibiotics (33.5%) followed by 
drugs acting on GIT (29.3%). It might be due to the reason that the 
antibiotics are prescribed more and used irrationally. The unavailability 
of therapeutic drug monitoring might also be the associated reason for 
antibiotics causing problems (Fig. 2). In the study, the least DRP was 
an adverse reaction (allergic) which is seen in only 2 patients. The 
drug associated with the reaction was antibiotics, and the reason was 
lack of hypersensitivity testing before the drug administration. The 
example for adverse reaction identified in this study was skin rashes 
due to gentamycin injection. Proper screening for any hypersensitivity 
of the antibiotics must be done before the administration of the drug to 
decrease this problem. Another DRP found was drug choice problem. 
The contributing factor was mainly improper prescribing by physician, 
improper nursing, and pharmacist supervision and the uncertain 
diagnosis leads to untreated indication. The drug associated was NSAIDs 
and drugs acting on GIT (ranitidine, etc.) followed by antibiotics. Lesser 
dosage and short duration of treatment were the most frequent DRP’s 
in dosing problem. The main reason was patient noncompliance which 
is either due to improper counseling or patient attitude to treatment 
and the early removal of symptoms with an initial incomplete dose 
of drugs (antibiotics). Therefore, efforts should be made to minimize 
these dosing errors such as the involvement of a pharmacist in deciding 
the dosing of drugs or a computerized dosing program.
In DRP belonging to drug use problem, two problems (drugs not taken 
and wrong drug taken) were noticed. These problems occurred at the 
patient level, i.e., because of the patients themselves. The physician 
prescribes the medicine but due to patient’s problems such as poverty, 
waiting of free distribution medicines, halting the medicines soon after 
the symptoms subsides and less knowledge regarding the drugs, these 
problems are arising. Mostly, the drug not taken was followed by wrong 
drug taken. Patients who are staying in wards for long time are buying 
the medicines for other patients of same ward also which leads to 
confusion and wrong drugs taken. Mostly, these problems are associated 
with the oral medicines where patients themselves administer the 
drugs. Some patients because of language barrier cannot interact with 
the health-care provider regarding the drug confusion ending up with 
wrong drug administration.
Drug interaction (47.55%) was the predominantly occurring problem. 
The findings were similar to studies by Dasari et al., who carried out DRP 
studies in a South Indian hospital [16] and Rijo et al., who conducted the 
similar study in Kochi [12]. This may be because prescribed antibiotics, 
anticoagulants are the drugs that interact with large number of other 
drugs, lack of medication history, lack of physician knowledge about 
drugs and polypharmacy. Few examples of drug-DI identified in this 
study involve drug interaction between ranitidine and theophylline, 
digoxcin with calcium channel blocker, etc. The DI identified in this 
study were mostly based on established literature and evidence (mostly 
potential). In clinical practice, several drugs can still be used together, yet 
close monitoring is fundamental, and any toxicity should be identified 
and immediately followed by corrective actions. Many of the patients 
in this study did not engage in regular physical activity, did not adhere 
to proper diets, did not perform any routine blood monitoring, and 
defaulted on follow-up or medications. This leads to others problems 
like therapy failure and also a problem of insufficient awareness.
CONCLUSION
Drugs can be useful tools in the prevention and treatment of 
symptoms and diseases, but if not used properly, they may be harmful 
and cause new symptoms or produce sub-optimal effects which are 
termed as DRPs. Polypharmacy, comorbidities, lack of awareness has 
been found as the reason for DRPs. This study presents a pattern of 
finding DRPs in a private tertiary care teaching hospital in India. The 
present results point to the establishment of a DRPs reporting system 
at each hospital and to share the data with other hospitals/healthcare 
settings. The role of a clinical pharmacist in this situation appears 
to be a strong intervention and very crucial one which depends on 
the pharmaceutical services provided by them and, the clinical 
pharmacist, initially, could only confine to identification of the DRPs, 
later bring those problems to the notice of physician and other health-
care professional and take precaution and measures to avoid them. 
Our study shows that DRPs are significantly occurring in hospital 
causing the patient for comorbidity, prolonged hospitalization, and 
increased financial burden. The study suggests that the pharmacists 
and general practitioners (physicians) can work together to identify 
and resolve DRPs.
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